🚀Our journey started in #Helsinki ten years ago. Now we are also in #Copenhagen and #Stockholm, and are able to service you locally in the #Nordics with our full range of solutions.
#HerOgNu. #HereAndNow. #MedEngine
💡Read more about our solutions: https://t.co/HOc7cJSYem
Bridging the gap between clinical research and registry studies, the MedEngine research team utilised register data available through Findata to validate a mathematical model for cancer treatments.
Read more ⬇️https://t.co/5NuwgQV0XZ
#SecondaryUse#HealthData#research
@reinoenbuske1 Tätä en kyllä tiennyt, vaikka olen kyllä kuullut Pasmoista. Eräs entinen työkaverikin kuului Pasman sukuun ja hänelle väitin kovasti että en ole hänelle sukua 😀 Mielenkiintoista, pitääpä kysellä isältä tarkemmin!
🚀Our journey started in #Helsinki ten years ago. Now we are also in #Copenhagen and #Stockholm, and are able to service you locally in the #Nordics with our full range of solutions.
#HerOgNu. #HereAndNow. #MedEngine
💡Read more about our solutions: https://t.co/HOc7cJSYem
🚨 Good news! Pharma industry veteran Sami Nikoskelainen joins #MedEngine and adds proficiency to all current and new projects across business units. A #WarmWelcome, Sami!
https://t.co/zPnd6Q2a2q
#TheValueIsInTheLinks
💡#MedEngine's Juulia Jylhävä was interviewed by @WIRED. "Instead of extending life spans we should focus on maximizing our health spans. It is more important to add life to years than years to life", she says.
#TheValueIsInTheLinks#Longevity#Health
https://t.co/9R8kEJCtCP
Together with our #ecosystem partners MedEngine & https://t.co/VEmHPUkDze, we explored the potential of creating a privacy-preserving, #GDPRcompliant, subject-level dataset that leverages the high-quality real-world data (#RWD) available in the #Nordics t…https://t.co/hVpN8QOshY
Tutkimusryhmämme kirjoittama katsaus perinnöllisestä sarveiskalvotulehduksesta (Keratis fugax hereditaria), joka edelleen tunnistetaan Suomessa (ja maailmalla) huonosti. @Duodecimlehti https://t.co/4B7tLmLCy0